Skip to main content
Contact Us
search

Benjamin Lewing

Author Biography

Benjamin.Lewing@inovalon.com
Connect on LinkedIn

Benjamin Lewing, PhD

Senior Manager, Health Economics and Outcomes Research

Benjamin serves as a research consultant within Inovalon’s Data Solutions team, and provides support for health economics and outcomes research projects. Benjamin is experienced in designing observational studies and retrospective database analyses. Prior to joining Inovalon, he held internships at Genentech, as part of their Evidence for Access team, and at Royal Dutch Shell, as part of their Health Risk Science team.

Benjamin has authored/co-authored numerous manuscripts published in peer-reviewed journals, including American Journal of Managed Care, Journal of Opioid Management, and Diabetes Epidemiology and Management. He has also presented scholarly work at numerous scientific conferences and received research awards from International Society for Pharmacoeconomics and Outcomes Research (ISPOR).

Benjamin received a PhD in pharmaceutical health outcomes and policy from University of Houston, where his dissertation examined the impact of inadequate care on health outcomes during management of type 2 diabetes, and the role of patient and health system factors in inadequate diabetes care. In addition to his PhD, Benjamin also holds a MA in applied economics from University of Houston, a MS in chemistry from Mississippi College, and a BS in biochemistry from Mississippi College.

Authored Content

Filter

May 3, 2023
Poster Presentation

Long COVID-19 Associated with 5-Fold Increase in Total Medical Costs and Greater Use of Inpatient and Outpatient Services Compared to Non-Long COVID-19: An Analysis of Real World Data.

Chacon-Araya M., Tkacz J.P., Zagari M., Bello T., Lewing B., Brusky S.
This study assessed real-world evidence data on the prevalence and impact of long COVID (LC) to establish a baseline for the value of potential therapeutic interventions.
Read More
May 3, 2023
Poster Presentation

Assessment of Medically-Attended COVID-19 Patient Risk Profiles and Health Care Resource Utilization (HCRU) and Costs in the U.S.

Chacon-Araya M., Tkacz J.P., Zagari M., Bello T., Lewing B., Brusky S.
This study assessed healthcare costs for medically attended COVID-19 (MAC) patients vs. matched controls not presenting with COVID-19, to serve as a baseline for the value of potential therapeutics.
Read More
March 21, 2023
Presentation

National Projection of U.S. Patients Potentially Ineligible for Existing COVID-19 Treatments

Chacon-Araya M, Tkacz JP, Zagari M, Bello T, Lewing B, Brusky S
Accepted for presentation at Academy of Managed Care Pharmacy 2023. Findings available upon request. Contact us for more information.
Read More
December 13, 2022
Presentation

Real-World Effectiveness and Economic Impact Associated with Chimeric Antigen Receptor T-Cell Therapy Among Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma in US

Chihara D, Liao L, Tkacz J, Lewing B, Franco A, Kilgore K, Nastoupil L, Chen L
The aim of the study was to examine the outcomes and economic impact among older patients with DLBCL receiving CAR T-cell therapy in a real-world setting in the United States.
Read More
December 10, 2022
Presentation

Real-World Effectiveness and Economic Impact Associated with Chimeric Antigen Receptor T-cell Therapy Among Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Chihara D, Liao L, Chen L,  Tkacz JP, Franco A, Lewing B, Kilgore K,   Nastoupil L 
Accepted for presentation at American Society of Hematology (ASH) Annual Meeting 2022. Findings available upon request. Contact us for more information.
Read More
October 11, 2022
Presentation

Cost of Care Among Severe, Persistent Asthma Patients Following Uncontrolled Status in the U.S.

Burnette A, Chung Y, Ambrose C, Spahn J, Rane P, Wang Y, Lindsley AW,  Tkacz JP, Mirza-Haq N, Lewing B, Carr T 
Accepted for presentation at Academy of Managed Care Pharmacy Nexus 2022. Findings available upon request. Contact us for more information.
Read More